drugset / Trial / NCT00210288

Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine

NCT00210288 ↗

Phase 2 Completed 111 enrolled Institut Pasteur
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to assess the immune response produced by two doses of SC599 vaccine compared to placebo.

Timeline

Start
2005-05
Primary completion
2006-09
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject SC599 Vaccine 100000 unknown Oral
Subject SC599 Vaccine 1e+07 unknown Oral

Indications